(a,b) ELISA immunoassay clearly demonstrates that leptin significantly decreases the levels of intracellular Aβ42 and Aβ40, while concomitant treatment with the SIRT1 inhibitor sirtinol mitigates the leptin-induced decrease in intracellular Aβ42 and Aβ40. (c,d) ELISA immunoassay clearly shows that leptin significantly decreases the levels of secreted forms of Aβ42 and Aβ40, while co-treatment with the SIRT1 inhibitor sirtinol significantly attenuates the leptin-induced decrease in secreted Aβ42 and Aβ40. Data is expressed as Mean + S.E.M and includes determinations made in four separate cell culture experiments (n=4). *p<0.05, **p<0.01, ***p<0.001 versus control; † p<0.05, †† p<0.01 versus leptin.